GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, APP, AR, AXL, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, FABP3, GRIK5, GRM5, GSK3B, HMGCR, HSD17B2, IDO1, IGF1R, MAOB, MMP2, MMP9, PPARA, PTAFR, PTGES, PTGS2, RELA, RORC, SRC, TYR |
10.6789 |
[BP] GO:0065008 |
regulation of biological quality
|
ABCG2, ACHE, ADORA1, AKR1B1, APP, AR, AURKB, AXL, CA12, CA2, CA7, CACNA1C, CYP19A1, CYP1A1, CYP1B1, DHFR, F3, FABP3, FABP4, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM5, GSK3B, HCAR2, HMGCR, HSD17B1, HSD17B2, HSD17B3, KDR, MAOA, MAOB, MET, PPARA, PTAFR, PTGS2, SLC1A1, SRC, XDH |
10.2412 |
[BP] GO:0010033 |
response to organic substance
|
AKR1B1, APP, AR, AXL, CA2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, FABP3, FABP4, FLT3, GRIK5, GRM5, GSK3B, HMGCR, HSD17B2, IDO1, IGF1R, KDR, MAOB, MMP2, PPARA, PTAFR, PTGES, PTGS2, RELA, RORC, SRC, TYR |
8.87851 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, AKR1B1, APP, AR, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, F3, FLT3, GRM1, GSK3B, HCAR2, HMGCR, KDR, MAP2K1, MAP3K7, MET, MMP12, MMP9, PDE5A, PTGS2, PTPN1, RELA, SRC, XDH |
8.60463 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, AKR1B1, APP, AR, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, F3, FLT3, GRM1, GSK3B, HCAR2, HMGCR, KDR, MAP2K1, MAP3K7, MET, MMP12, MMP9, PDE5A, PTGS2, PTPN1, RELA, SRC, XDH |
8.60463 |
[BP] GO:0044281 |
small molecule metabolic process
|
ABCG2, AKR1B1, AKR1B10, ALOX5, APP, CA1, CA12, CA2, CA4, CA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, FABP3, FUT7, HMGCR, HSD17B3, IDO1, PDE5A, PIM1, PPARA, PTAFR, PTGES, PTGS2, TYR, XDH |
8.37252 |
[BP] GO:0042221 |
response to chemical
|
ABCG2, AKR1B1, APP, AR, AXL, CA2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, FABP3, FABP4, FLT3, GRIK5, GRM5, GSK3B, HMGCR, HSD17B2, IDO1, IGF1R, KDR, MAOB, MMP2, MMP9, PPARA, PTAFR, PTGES, PTGS2, RELA, RORC, SRC, TYR |
8.37252 |
[BP] GO:0007215 |
None
|
APP, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
8.17062 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, AKR1B1, APP, AR, CDC25B, CSNK2A1, CYP1B1, F3, FABP3, FLT3, HMGCR, IDO1, IGF1R, KDR, MAP2K1, MMP12, MMP2, MMP9, PDE5A, PIM1, PTAFR, PTGES, PTGS2, RELA, SRC, XDH |
8.16157 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, AR, AURKB, AXL, CSNK2A1, CYP1B1, F3, FLT3, GRIK5, GSK3B, HCAR2, HMGCR, IDO1, IGF1R, KDR, MAP2K1, MET, MMP9, PIM1, PPARA, PTGS2, PTPN1, RELA, SRC, XDH |
7.48731 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, ADORA1, AKR1B1, APP, AR, AURKB, AXL, CA2, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DHFR, F3, FABP3, FABP4, FLT3, GRIK5, GRM1, GRM5, GSK3B, HCAR2, HMGCR, IDO1, IGF1R, KDR, MAOB, MAP2K1, MAP3K7, MET, MMP1, MMP12, MMP2, MMP9, PDE5A, PIM1, PPARA, PTAFR, PTGS2, PTPN1, RELA, RORC, SLC1A1, SRC, XDH |
7.48731 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, AR, AURKB, AXL, CSNK2A1, CYP1B1, F3, FLT3, GRIK5, GSK3B, HCAR2, HMGCR, IDO1, IGF1R, KDR, MAP2K1, MET, MMP9, PIM1, PTGS2, PTPN1, RELA, SRC, XDH |
7.40817 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, AKR1B1, APP, AR, AURKB, AXL, CA2, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, F3, FABP3, FLT3, GRIK5, GRM1, GRM5, GSK3B, HCAR2, HMGCR, IDO1, IGF1R, KDR, MAOB, MAP2K1, MAP3K7, MET, MMP1, MMP12, MMP2, MMP9, PDE5A, PIM1, PPARA, PTAFR, PTGS2, PTPN1, RELA, RORC, SRC, XDH |
7.33385 |
[BP] GO:0033993 |
response to lipid
|
AR, AXL, CA2, CSNK2A1, CYP1A1, CYP1A2, FABP3, FLT3, HSD17B2, IDO1, MAOB, PTAFR, PTGES, PTGS2, RELA, RORC, SRC, TYR |
7.26456 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, AKR1B1, APP, AR, AURKB, AXL, CA2, CA7, CACNA1C, CSNK2A1, CYP19A1, CYP1B1, F3, FLT3, GRIK5, GRM1, GRM3, GRM5, GRM8, GSK3B, HCAR2, HMGCR, IGF1R, KDR, MAP2K1, MAP3K7, MET, MMP12, MMP9, PDE5A, PTGS2, PTPN1, RELA, SRC, XDH |
7.21525 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, APP, AXL, CA2, CYP1A1, CYP1A2, CYP1B1, FABP4, KDR, MAOB, MMP9, PTGES, PTGS2, RELA, SRC |
7.18171 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, AKR1B1, APP, AR, AURKB, AXL, CA2, CA7, CACNA1C, CSNK2A1, CYP19A1, CYP1B1, F3, FLT3, GRIK5, GRM1, GRM3, GRM5, GRM8, GSK3B, HCAR2, HMGCR, IGF1R, KDR, MAP2K1, MAP3K7, MET, MMP12, MMP9, PDE5A, PTGS2, PTPN1, RELA, SRC, XDH |
7.1009 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, APP, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, FUT7, HMGCR, HSD17B1, HSD17B2, HSD17B3, MET, PPARA, PTGES, PTGS2 |
7.05622 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, AKR1B1, APP, AR, AXL, CYP1B1, F3, FLT3, GRM1, HMGCR, KDR, MAP2K1, MAP3K7, MET, PDE5A, PTGS2, PTPN1, RELA, SRC, XDH |
7.01023 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, AR, AURKB, AXL, CSNK2A1, CYP1B1, F3, FLT3, GRIK5, GSK3B, HCAR2, HMGCR, IDO1, IGF1R, KDR, MAP2K1, MMP9, PIM1, PTGS2, PTPN1, RELA, SRC, XDH |
6.85856 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, AKR1B1, APP, AR, AXL, CSNK2A1, CYP1B1, F3, FLT3, GRM1, GSK3B, HMGCR, KDR, MAP2K1, MAP3K7, MET, MMP12, MMP9, PDE5A, PTGS2, PTPN1, RELA, SRC, XDH |
6.82189 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, GSK3B, HMGCR, HSD17B1, HSD17B2, HSD17B3, IDO1, MAOA, MAOB, PTGS2, TYR, XDH |
6.80254 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, AKR1B1, APP, AR, AXL, CSNK2A1, CYP1B1, F3, FABP4, FLT3, GRM1, GSK3B, HMGCR, IDO1, KDR, MAP2K1, MAP3K7, MET, MMP12, MMP2, MMP9, PDE5A, PTAFR, PTGS2, PTPN1, RELA, SRC, XDH |
6.52516 |
[BP] GO:0014070 |
response to organic cyclic compound
|
APP, AR, CA2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, FLT3, MAOB, PTAFR, PTGES, PTGS2, RELA, RORC, SRC, TYR |
6.45407 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, AR, AURKB, AXL, CSNK2A1, GSK3B, HMGCR, IDO1, IGF1R, KDR, MET, MMP9, PIM1, PPARA, PTGS2, PTPN1, RELA, SRC |
6.40498 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, AR, AURKB, AXL, CSNK2A1, GSK3B, HMGCR, IDO1, IGF1R, KDR, MET, MMP9, PIM1, PTGS2, PTPN1, RELA, SRC |
6.17592 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, APP, CYP19A1, CYP1A1, CYP1A2, CYP1B1, HMGCR, HSD17B1, HSD17B2, HSD17B3 |
6.12545 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADORA1, ADORA3, APP, AR, AXL, CA2, CA7, CACNA1C, CSNK2A1, CYP19A1, CYP1B1, F3, GRIK5, GRM5, GSK3B, HCAR2, HMGCR, IGF1R, KDR, MAOB, MAP2K1, MET, MMP12, MMP9, PPARA, PTAFR, PTGS2, PTPN1, SRC |
6.0643 |
[BP] GO:0050896 |
response to stimulus
|
ABCG2, ACHE, ADORA1, ADORA3, AKR1B1, APP, AR, AURKB, AXL, CA2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, F3, FABP3, FABP4, FLT3, GRIK5, GRM1, GRM5, GSK3B, HMGCR, HSD17B2, IDO1, IGF1R, KDR, MAOB, MAP2K1, MAP3K7, MMP12, MMP2, MMP9, PPARA, PTAFR, PTGES, PTGS2, PTPN1, RELA, RORC, SRC, TYR |
5.88447 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, APP, CYP19A1, CYP1A1, CYP1B1, DHFR, HMGCR, HSD17B3, MAOA, MAOB, PTAFR, TYR |
5.88099 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, AKR1B1, AKR1B10, ALOX5, APP, AR, AXL, CACNA1C, CYP19A1, CYP1A2, CYP1B1, F3, FABP4, GRM1, GRM5, GRM8, HMGCR, HSD17B2, IDO1, IGF1R, MET, MMP1, MMP12, MMP2, MMP9, PDE5A, PIM1, PPARA, PTAFR, PTGS2, RELA, RORC, SRC, TYR |
5.80081 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA7, DHFR |
5.7769 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, APP, AR, CDC25B, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, HMGCR, IGF1R, KDR, MAP2K1, MAP3K7, MMP9, PDE5A, PPARA, PTAFR, PTGS2, PTPN1, SRC, XDH |
5.7769 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, APP, AR, CDC25B, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, HMGCR, IGF1R, KDR, MAP2K1, MAP3K7, MMP9, PDE5A, PPARA, PTAFR, PTGS2, PTPN1, SRC, XDH |
5.71865 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, AR, AURKB, AXL, CSNK2A1, GSK3B, HMGCR, IDO1, IGF1R, KDR, MMP9, PIM1, PTGS2, PTPN1, RELA, SRC |
5.51111 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, APP, AR, CDC25B, FABP3, FLT3, GRM1, GRM5, HMGCR, KDR, MAP2K1, MAP3K7, MMP9, PDE5A, PTAFR, PTGS2, PTPN1, SRC, XDH |
5.49265 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, APP, AR, CDC25B, FABP3, FLT3, GRM1, GRM5, HMGCR, KDR, MAP2K1, MAP3K7, MMP9, PDE5A, PTAFR, PTGS2, PTPN1, SRC, XDH |
5.49265 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, APP, AR, CA2, CSNK2A1, CYP1A2, FABP3, FLT3, GRM5, GSK3B, IGF1R, MAOB, MMP2, PPARA, PTAFR, PTGS2, RELA, SRC |
5.47062 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, APP, AR, AXL, CYP1B1, GRIK5, GRM5, GSK3B, IGF1R, MMP2, MMP9, PTAFR, PTGS2, RELA, RORC, SRC |
5.47062 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, AKR1B1, APP, AR, AURKB, AXL, CSNK2A1, CYP1B1, F3, FLT3, GRM1, HMGCR, IGF1R, KDR, MAP2K1, MAP3K7, MET, MMP9, PDE5A, PTGS2, PTPN1, RELA, SRC, XDH |
5.45719 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
APP, AR, AXL, CA2, CYP1B1, F3, HCAR2, HMGCR, IDO1, KDR, MAP2K1, MAP3K7, MET, MMP12, MMP9, PDE5A, PIM1, PTAFR, PTGS2, RELA, SLC1A1, SRC |
5.3999 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, ADORA1, APP, CA2, CA7, GRIK5, GRM1, GRM3, GRM5, GRM8, PTGS2 |
5.3999 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, ADORA1, APP, CA2, CA7, GRIK5, GRM1, GRM3, GRM5, GRM8, PTGS2 |
5.3999 |
[BP] GO:0007166 |
cell surface receptor signaling pathway
|
ADORA1, ADORA3, APP, AXL, CA1, CSNK2A1, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, GSK3B, IGF1R, KDR, MAP3K7, MET, MMP2, MMP9, PTAFR, PTPN1, RELA, SRC |
5.38279 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA7 |
5.34617 |
[BP] GO:0001101 |
response to acid chemical
|
AKR1B1, DHFR, FABP3, HSD17B2, KDR, MMP2, PTAFR, PTGES, PTGS2, RELA, SRC |
5.13186 |
[BP] GO:0007196 |
None
|
GRM1, GRM3, GRM5, GRM8 |
5.12648 |
[BP] GO:0080134 |
regulation of response to stress
|
ADORA1, APP, CYP19A1, DHFR, F3, FABP4, GSK3B, HMGCR, IDO1, IGF1R, MAP2K1, MAP3K7, MET, MMP12, MMP2, PPARA, PTGS2, PTPN1, RELA, SRC, XDH |
5.08593 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
ADORA1, APP, AR, CDC25B, CSNK2A1, F3, FLT3, GRM1, GRM5, GSK3B, HMGCR, KDR, MAP2K1, MAP3K7, MMP9, PDE5A, PTAFR, PTGS2, PTPN1, RELA, SRC, XDH |
5.04309 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADORA1, APP, AR, CDC25B, FLT3, GRM1, GRM5, HMGCR, KDR, MAP2K1, MAP3K7, MMP9, PDE5A, PTGS2, PTPN1, SRC, XDH |
5.0066 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, CYP1A1, CYP1A2, CYP1B1, TYR |
5.0066 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADORA1, APP, AR, FLT3, GRM1, HMGCR, KDR, MAP2K1, MAP3K7, PDE5A, PTPN1, SRC, XDH |
5.0066 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, APP, AR, AXL, CYP1A1, CYP1A2, CYP1B1, FABP4, FLT3, GRIK5, GRM5, GSK3B, IGF1R, KDR, MMP2, MMP9, PTAFR, PTGS2, RELA, RORC, SRC |
5.00613 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, APP, AR, AURKB, AXL, CA2, CYP1A1, CYP1A2, CYP1B1, DHFR, FABP4, FLT3, GRIK5, GRM1, GRM5, GSK3B, IGF1R, KDR, MAP2K1, MAP3K7, MMP2, MMP9, PTAFR, PTGS2, PTPN1, RELA, RORC, SRC |
4.97858 |
[BP] GO:2001225 |
regulation of chloride transport
|
CA2, CA7, GRM5, PTAFR |
4.9658 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, APP, AR, AXL, CYP1A1, CYP1B1, FABP4, FLT3, GRIK5, GRM5, GSK3B, IGF1R, KDR, MMP2, PTAFR, PTGS2, RELA, RORC, SRC |
4.96445 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA1, ADORA3, APP, AR, AURKB, CDC25B, CSNK2A1, DHFR, F3, FABP4, FLT3, GRM1, GRM3, GRM5, GSK3B, HMGCR, IGF1R, MAP2K1, MAP3K7, MMP9, PDE5A, PTAFR, PTGS2, PTPN1, SRC, XDH |
4.93979 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AKR1B10, AURKB, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, FUT7, GSK3B, IDO1, MAOA, MAOB, MMP1, MMP12, MMP2, MMP9, PDE5A, SRC, XDH |
4.84384 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADORA1, APP, AR, CDC25B, FLT3, GRM1, GRM5, HMGCR, KDR, MAP2K1, MAP3K7, MMP9, PDE5A, PTGS2, PTPN1, SRC, XDH |
4.7963 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, APP, DHFR, FABP3, FLT3, GRM5, GSK3B, IGF1R, MMP2, PPARA, PTAFR, PTGS2, RELA, SRC, TYR |
4.72886 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADORA1, APP, AR, AURKB, CDC25B, CSNK2A1, DHFR, F3, FABP3, FLT3, GRM1, GRM5, GSK3B, HMGCR, IGF1R, KDR, MAOB, MAP2K1, MAP3K7, MET, MMP12, MMP9, PDE5A, PPARA, PTAFR, PTGS2, PTPN1, RELA, RORC, SRC, XDH |
4.71654 |
[BP] GO:0051966 |
regulation of synaptic transmission, glutamatergic
|
ADORA1, GRM1, GRM3, GRM5, GRM8, PTGS2 |
4.70914 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, AR, CDC25B, CSNK2A1, F3, FLT3, HMGCR, IGF1R, KDR, MMP12, MMP2, MMP9, PIM1, PTAFR, PTGS2, RELA |
4.7038 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, APP, AR, AURKB, CDC25B, CSNK2A1, F3, FLT3, GRM1, GRM5, GSK3B, HMGCR, IGF1R, KDR, MAOB, MAP2K1, MAP3K7, MET, MMP12, MMP9, PDE5A, PPARA, PTAFR, PTGS2, PTPN1, RELA, RORC, SRC, XDH |
4.65975 |
[BP] GO:0065009 |
regulation of molecular function
|
ADORA1, ADORA3, APP, AR, AURKB, CDC25B, CSNK2A1, CYP1B1, DHFR, F3, FABP4, FLT3, GRM1, GRM3, GRM5, GSK3B, HMGCR, IGF1R, MAP2K1, MAP3K7, MET, MMP9, PDE5A, PIM1, PPARA, PTAFR, PTGS2, PTPN1, RELA, SRC, XDH |
4.53707 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, HSD17B1, HSD17B2, HSD17B3 |
4.48646 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AR, AXL, CA2, CACNA1C, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, FLT3, HSD17B2, HSD17B3, KDR, MAP2K1, PPARA, RELA, SRC, TYR |
4.45937 |
[BP] GO:0007216 |
None
|
GRM1, GRM3, GRM5, GRM8 |
4.39568 |
[BP] GO:0007165 |
signal transduction
|
ADORA1, ADORA3, AKR1B1, APP, AR, AXL, CA1, CA2, CACNA1C, CSNK2A1, CYP1B1, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, GSK3B, HCAR2, IGF1R, KDR, MAP2K1, MAP3K7, MET, MMP2, MMP9, PDE5A, PIM1, PPARA, PTAFR, PTGES, PTPN1, RELA, RORC, SRC |
4.39568 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, APP, DHFR, FABP3, FLT3, GRM5, GSK3B, IGF1R, MMP2, PPARA, PTAFR, PTGS2, RELA, SRC, TYR |
4.35856 |
[BP] GO:0042180 |
None
|
AKR1B1, AKR1B10, CYP19A1, HMGCR, HSD17B3, IDO1 |
4.34747 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, APP, AR, AURKB, CDC25B, F3, FABP3, FLT3, GRM1, GRM5, GSK3B, HMGCR, IGF1R, KDR, MAOB, MAP2K1, MAP3K7, MET, MMP12, MMP9, PDE5A, PPARA, PTAFR, PTGS2, PTPN1, RELA, RORC, SRC, XDH |
4.34399 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, APP, AR, CDC25B, FABP4, FLT3, GRM1, GRM5, HMGCR, IGF1R, KDR, MAP2K1, MAP3K7, MMP9, PDE5A, PPARA, PTGS2, PTPN1, SRC, XDH |
4.33613 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA1, ADORA3, APP, AR, AXL, CA2, CACNA1C, CYP1B1, F3, GRM1, GSK3B, HCAR2, HMGCR, IDO1, KDR, MAP2K1, MAP3K7, MET, MMP12, MMP9, PDE5A, PIM1, PTAFR, PTGS2, RELA, SLC1A1, SRC, XDH |
4.33033 |
[BP] GO:0008152 |
metabolic process
|
ABCG2, ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, APP, AR, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, F3, FABP3, FABP4, FLT3, FUT7, GSK3B, HMGCR, HSD17B1, HSD17B2, HSD17B3, IDO1, IGF1R, KDR, MAOA, MAOB, MAP2K1, MAP3K7, MET, MMP1, MMP12, MMP2, MMP9, PDE5A, PIM1, PPARA, PTAFR, PTGES, PTGS2, PTPN1, RELA, RORC, SRC, TYR, XDH |
4.32318 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ADORA1, APP, AR, FLT3, GRM1, HMGCR, IGF1R, KDR, MAP2K1, MAP3K7, PDE5A, PTPN1, SRC, XDH |
4.29494 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, AKR1B1, CACNA1C, CYP19A1, CYP1A1, CYP1B1, HCAR2, HMGCR, HSD17B1, HSD17B2, HSD17B3 |
4.25561 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ADORA1, APP, AR, CDC25B, FABP4, FLT3, GRM1, GRM5, HMGCR, IGF1R, KDR, MAP2K1, MAP3K7, MMP9, PDE5A, PTGS2, PTPN1, SRC, XDH |
4.25189 |
[BP] GO:0032270 |
positive regulation of cellular protein metabolic process
|
ADORA1, APP, AR, CDC25B, F3, FLT3, GRM1, GRM5, GSK3B, HMGCR, KDR, MAP2K1, MAP3K7, MMP9, PDE5A, PTAFR, PTGS2, PTPN1, SRC, XDH |
4.24166 |
[BP] GO:0051049 |
regulation of transport
|
ACHE, ADORA1, APP, AXL, CA2, CA7, CACNA1C, CYP19A1, GRIK5, GRM5, GSK3B, HCAR2, HMGCR, MAOB, MAP2K1, MMP12, MMP9, PPARA, PTAFR, PTGS2, PTPN1, SRC |
4.1994 |
[BP] GO:0042493 |
response to drug
|
ABCG2, AKR1B1, AXL, CYP1A1, CYP1B1, DHFR, FABP3, HMGCR, KDR, MAOB, PTAFR, PTGS2, RELA, SRC |
4.19388 |
[BP] GO:0048661 |
positive regulation of smooth muscle cell proliferation
|
AKR1B1, HMGCR, MMP2, MMP9, PTAFR, PTGS2 |
4.16427 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, HSD17B1, HSD17B2, HSD17B3 |
4.15437 |
[BP] GO:0043405 |
regulation of MAP kinase activity
|
ADORA1, FLT3, GRM1, HMGCR, IGF1R, MAP2K1, MAP3K7, PDE5A, PTPN1, SRC |
4.11892 |
[BP] GO:0044283 |
None
|
AKR1B1, ALOX5, CYP19A1, CYP1A1, DHFR, HMGCR, HSD17B3, IDO1, PTAFR, PTGES, PTGS2 |
4.05259 |
[BP] GO:0044093 |
positive regulation of molecular function
|
ADORA1, APP, AR, AURKB, CDC25B, DHFR, F3, FLT3, GRM1, GRM5, GSK3B, MAP2K1, MAP3K7, MET, MMP9, PDE5A, PTAFR, PTPN1, RELA, SRC, XDH |
4.05211 |
[BP] GO:0051338 |
regulation of transferase activity
|
ADORA1, APP, AURKB, CDC25B, FABP4, FLT3, GRM1, GRM5, GSK3B, HMGCR, IGF1R, MAP2K1, MAP3K7, PDE5A, PTPN1, SRC |
4.04516 |
[BP] GO:1901652 |
response to peptide
|
AKR1B1, APP, FABP3, GRM5, GSK3B, IGF1R, PPARA, PTGS2, RELA, SRC |
4.04516 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, APP, AR, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, DHFR, FABP3, FABP4, GRM3, GRM8, GSK3B, HMGCR, IDO1, IGF1R, KDR, MAOB, MAP2K1, MET, MMP12, MMP9, PDE5A, PIM1, PPARA, PTGES, PTGS2, PTPN1, RELA, RORC, SRC, XDH |
4.02915 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, FLT3, GSK3B, IGF1R, KDR, PIM1, SRC |
4.01048 |
[BP] GO:0009725 |
response to hormone
|
AKR1B1, AR, CA2, CSNK2A1, CYP1A2, FABP3, FLT3, MAOB, PPARA, PTAFR, PTGS2, RELA, SRC |
3.98727 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, APP, AURKB, CSNK2A1, CYP1B1, FABP4, GRM3, GSK3B, HMGCR, IGF1R, MET, MMP9, PIM1, PPARA, PTGS2, PTPN1, SRC |
3.98149 |
[BP] GO:0065007 |
biological regulation
|
ABCG2, ACHE, ADORA1, ADORA3, AKR1B1, APP, AR, AURKB, AXL, CA1, CA12, CA2, CA7, CACNA1C, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, F3, FABP3, FABP4, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, GSK3B, HCAR2, HMGCR, HSD17B1, HSD17B2, HSD17B3, IDO1, IGF1R, KDR, MAOA, MAOB, MAP2K1, MAP3K7, MET, MMP1, MMP12, MMP2, MMP9, PDE5A, PIM1, PPARA, PTAFR, PTGES, PTGS2, PTPN1, RELA, RORC, SLC1A1, SRC, XDH |
3.98149 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, AKR1B1, APP, AR, AXL, CA2, CACNA1C, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, FLT3, GSK3B, HSD17B2, HSD17B3, KDR, MAOB, MAP2K1, MMP9, PIM1, PPARA, PTGS2, RELA, RORC, SRC, TYR |
3.96034 |
[BP] GO:0032496 |
response to lipopolysaccharide
|
AXL, CYP1A1, CYP1A2, IDO1, MAOB, PTGES, PTGS2, RELA, SRC |
3.93566 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, CYP1A1, FABP3, FLT3, HCAR2, HMGCR, PPARA, PTGS2, RORC, SRC |
3.93286 |
[BP] GO:0045859 |
regulation of protein kinase activity
|
ADORA1, APP, CDC25B, FABP4, FLT3, GRM1, GRM5, HMGCR, IGF1R, MAP2K1, MAP3K7, PDE5A, PTPN1, SRC |
3.92504 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, APP, AURKB, AXL, CDC25B, CSNK2A1, DHFR, FLT3, GSK3B, HMGCR, IGF1R, KDR, MAP2K1, MAP3K7, MET, PDE5A, PIM1, PTAFR, PTGS2, PTPN1, SRC, XDH |
3.90477 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADORA1, APP, AR, AURKB, CDC25B, CSNK2A1, F3, FLT3, GRM1, GRM5, GSK3B, HMGCR, IGF1R, KDR, MAP2K1, MAP3K7, MET, MMP12, MMP9, PDE5A, PPARA, PTAFR, PTGS2, PTPN1, RELA, RORC, SRC, XDH |
3.86707 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ADORA1, AKR1B1, APP, AR, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, DHFR, F3, FABP4, FLT3, GRM1, GSK3B, HMGCR, IDO1, IGF1R, KDR, MAP2K1, MAP3K7, MET, MMP12, MMP2, MMP9, PDE5A, PPARA, PTAFR, PTGS2, PTPN1, RELA, SRC, XDH |
3.86707 |
[BP] GO:0031401 |
positive regulation of protein modification process
|
ADORA1, APP, AR, CDC25B, FLT3, GRM1, GRM5, HMGCR, KDR, MAP2K1, MAP3K7, MMP9, PDE5A, PTGS2, PTPN1, SRC, XDH |
3.80755 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, AKR1B1, APP, AR, AURKB, AXL, CA2, CACNA1C, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, FABP4, FLT3, FUT7, GSK3B, HMGCR, HSD17B2, HSD17B3, KDR, MAOB, MAP2K1, MET, MMP2, MMP9, PIM1, PPARA, PTGS2, RELA, RORC, SRC, TYR |
3.74524 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ABCG2, ACHE, AKR1B1, APP, AR, AURKB, AXL, CDC25B, CSNK2A1, CYP1A1, CYP1A2, DHFR, F3, FLT3, FUT7, GSK3B, HMGCR, IDO1, IGF1R, KDR, MAOA, MAOB, MAP2K1, MAP3K7, MET, MMP1, MMP12, MMP2, MMP9, PDE5A, PIM1, PPARA, PTGS2, PTPN1, RELA, SRC, TYR, XDH |
3.73763 |
[BP] GO:0002237 |
response to molecule of bacterial origin
|
AXL, CYP1A1, CYP1A2, IDO1, MAOB, PTGES, PTGS2, RELA, SRC |
3.73621 |
[BP] GO:0048545 |
response to steroid hormone
|
AR, CA2, FLT3, MAOB, PTAFR, PTGS2, RELA, SRC |
3.71397 |
[BP] GO:0044237 |
cellular metabolic process
|
ABCG2, ACHE, AKR1B1, AKR1B10, ALOX5, APP, AR, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, FABP3, FABP4, FLT3, FUT7, GSK3B, HMGCR, HSD17B1, HSD17B2, HSD17B3, IDO1, IGF1R, KDR, MAOA, MAOB, MAP2K1, MAP3K7, MET, MMP1, MMP2, PDE5A, PIM1, PPARA, PTAFR, PTGES, PTGS2, PTPN1, RELA, RORC, SRC, TYR, XDH |
3.67798 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX5, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, FUT7, HMGCR, MET, PPARA, PTGES, PTGS2 |
3.67085 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, PTGES, PTGS2 |
3.6675 |
[BP] GO:0071417 |
cellular response to organonitrogen compound
|
AKR1B1, APP, GRM5, GSK3B, IGF1R, MMP2, PTAFR, PTGS2, RELA, SRC |
3.65374 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, AKR1B1, APP, AR, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, DHFR, FABP3, FABP4, GRM3, GRM8, GSK3B, HCAR2, HMGCR, IDO1, IGF1R, KDR, MAOB, MAP2K1, MET, MMP12, MMP9, PDE5A, PIM1, PPARA, PTGES, PTGS2, PTPN1, RELA, RORC, SRC, XDH |
3.65258 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, PTGES, PTGS2 |
3.64635 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, APP, AURKB, AXL, CDC25B, CSNK2A1, DHFR, FLT3, GSK3B, HMGCR, IGF1R, KDR, MAP2K1, MAP3K7, MET, PDE5A, PIM1, PTAFR, PTGS2, PTPN1, SRC, XDH |
3.62929 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.62687 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1, MAOB |
3.62687 |
[BP] GO:0043549 |
regulation of kinase activity
|
ADORA1, APP, CDC25B, FABP4, FLT3, GRM1, GRM5, HMGCR, IGF1R, MAP2K1, MAP3K7, PDE5A, PTPN1, SRC |
3.62687 |
[BP] GO:1901617 |
organic hydroxy compound biosynthetic process
|
AKR1B1, CYP19A1, DHFR, HMGCR, HSD17B3, PTAFR, TYR |
3.55908 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, PTGES, PTGS2 |
3.53143 |
[BP] GO:0010038 |
response to metal ion
|
APP, CA2, CYP1A1, CYP1A2, FABP4, MAOB, MMP9, PTGES, PTGS2 |
3.52987 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, AKR1B1, APP, AURKB, CA2, CYP1A1, GRM1, HMGCR, MMP2, PPARA, PTAFR, PTGS2, RELA, SRC, TYR |
3.51148 |
[BP] GO:0035235 |
None
|
APP, GRIA2, GRIA4, GRIK5 |
3.50405 |
[BP] GO:0031399 |
regulation of protein modification process
|
ADORA1, APP, AR, CDC25B, FABP4, FLT3, GRM1, GRM5, HMGCR, IGF1R, KDR, MAP2K1, MAP3K7, MMP9, PDE5A, PTGS2, PTPN1, RELA, SRC, XDH |
3.46536 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, AXL, CYP1B1, MMP9, RELA, SRC |
3.45865 |
[BP] GO:0050665 |
hydrogen peroxide biosynthetic process
|
CYP1A1, CYP1A2, MAOB |
3.45865 |
[BP] GO:1904646 |
cellular response to amyloid-beta
|
APP, GRM5, GSK3B, IGF1R |
3.45308 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, HSD17B1, HSD17B2, HSD17B3 |
3.43894 |
[BP] GO:1901699 |
cellular response to nitrogen compound
|
AKR1B1, APP, GRM5, GSK3B, IGF1R, MMP2, PTAFR, PTGS2, RELA, SRC |
3.4152 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, APP, CACNA1C, CYP19A1, CYP1B1, F3, IGF1R, KDR, MET, MMP9, PTAFR, PTGS2, SRC |
3.41483 |
[BP] GO:0032268 |
regulation of cellular protein metabolic process
|
ADORA1, APP, AR, CDC25B, CSNK2A1, DHFR, F3, FABP4, FLT3, GRM1, GRM5, GSK3B, HMGCR, IGF1R, KDR, MAP2K1, MAP3K7, MMP9, PDE5A, PTAFR, PTGS2, PTPN1, RELA, SRC, XDH |
3.38952 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
AR, MAP3K7, PIM1, PPARA, RELA, RORC, SRC |
3.38819 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, APP, CYP19A1, CYP1B1, F3, IGF1R, KDR, MET, MMP9, PTAFR, PTGS2, SRC |
3.3874 |
[BP] GO:1901654 |
None
|
AKR1B1, AR, CSNK2A1, MAOB, PTAFR, RELA, SRC |
3.3474 |
[BP] GO:0001505 |
regulation of neurotransmitter levels
|
ACHE, CYP1B1, DHFR, GRIK5, MAOA, MAOB, PTGS2, SLC1A1 |
3.33652 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
ADORA1, CYP19A1, F3, FABP4, HMGCR, IDO1, KDR, MAP2K1, MET, MMP12, PPARA, PTGS2, RELA |
3.33104 |
[BP] GO:1904645 |
response to amyloid-beta
|
APP, GRM5, GSK3B, IGF1R |
3.3013 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, CSNK2A1, CYP19A1, CYP1A1, HMGCR, HSD17B1, HSD17B2, HSD17B3, PTGES, PTGS2 |
3.29502 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
APP, AR, CYP1A1, CYP1B1, FLT3, PTAFR, PTGS2, RORC, SRC |
3.26336 |
[BP] GO:0042592 |
homeostatic process
|
ABCG2, ADORA1, AKR1B1, APP, AXL, CA12, CA2, CA7, CACNA1C, FABP3, FABP4, FLT3, GRIK5, GRM1, GRM5, MET, SRC |
3.25803 |
[BP] GO:0043406 |
positive regulation of MAP kinase activity
|
ADORA1, FLT3, GRM1, MAP2K1, MAP3K7, PDE5A, PTPN1, SRC |
3.24727 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, FLT3, IGF1R, KDR, MAP2K1, MET, SRC |
3.24727 |
[BP] GO:0006468 |
protein phosphorylation
|
APP, AURKB, AXL, CDC25B, CSNK2A1, FLT3, GSK3B, IGF1R, KDR, MAP2K1, MAP3K7, MET, PIM1, SRC |
3.22414 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
AKR1B1, APP, AR, FLT3, GRM5, GSK3B, IGF1R, MMP2, PTAFR, PTGS2, RELA, SRC |
3.21305 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, FLT3, IGF1R, KDR, MAP2K1, MET, SRC |
3.20901 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.19844 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, CYP19A1, HMGCR, HSD17B1, HSD17B2, HSD17B3 |
3.14495 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, APP, CYP19A1, CYP1B1, F3, IGF1R, KDR, MET, MMP9, PTAFR, PTGS2, SRC |
3.13441 |
[BP] GO:0048660 |
regulation of smooth muscle cell proliferation
|
AKR1B1, HMGCR, MMP2, MMP9, PTAFR, PTGS2 |
3.11036 |
[BP] GO:0008285 |
negative regulation of cell proliferation
|
ADORA1, ADORA3, APP, AR, CYP1B1, FABP3, IDO1, MAP2K1, PDE5A, PTGES, PTGS2, XDH |
3.10296 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, AURKB, CA2, CA7, CACNA1C, HCAR2, HMGCR, KDR, PTGS2, SRC |
3.0951 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, AXL, CYP1B1, KDR, PTAFR, PTGS2, RELA, SRC |
3.07257 |
[BP] GO:0007193 |
None
|
ADORA1, GRM1, GRM3, GRM5, GRM8 |
3.05194 |
[BP] GO:0043085 |
positive regulation of catalytic activity
|
ADORA1, APP, AURKB, CDC25B, DHFR, F3, FLT3, GRM1, GRM5, GSK3B, MAP2K1, MAP3K7, PDE5A, PTAFR, PTPN1, SRC, XDH |
3.04819 |
[BP] GO:0009987 |
cellular process
|
ABCG2, ACHE, ADORA1, ADORA3, AKR1B1, AKR1B10, ALOX5, APP, AR, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CACNA1C, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, F3, FABP3, FABP4, FLT3, FUT7, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, GSK3B, HCAR2, HMGCR, HSD17B1, HSD17B2, HSD17B3, IDO1, IGF1R, KDR, MAOA, MAOB, MAP2K1, MAP3K7, MET, MMP1, MMP12, MMP2, MMP9, PDE5A, PIM1, PPARA, PTAFR, PTGES, PTGS2, PTPN1, RELA, RORC, SLC1A1, SRC, TYR, XDH |
3.03265 |
[BP] GO:0060078 |
None
|
ADORA1, GRIA2, GRIA4, GRIK5, GRM5 |
3.0309 |
[BP] GO:0043393 |
regulation of protein binding
|
APP, AURKB, GSK3B, MET, MMP9, PPARA, SRC |
3.01565 |
[BP] GO:1901653 |
cellular response to peptide
|
AKR1B1, APP, GRM5, GSK3B, IGF1R, RELA, SRC |
2.98126 |
[BP] GO:0043065 |
positive regulation of apoptotic process
|
CYP1B1, F3, GRIK5, GSK3B, HCAR2, HMGCR, IDO1, MMP9, PTGS2, SRC, XDH |
2.97227 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, FABP3, PPARA, PTGES, PTGS2 |
2.94204 |
[BP] GO:0043068 |
positive regulation of programmed cell death
|
CYP1B1, F3, GRIK5, GSK3B, HCAR2, HMGCR, IDO1, MMP9, PTGS2, SRC, XDH |
2.9367 |
[BP] GO:0044070 |
regulation of anion transport
|
ADORA1, CA2, CA7, GRM5, PTAFR |
2.91461 |
[BP] GO:0071900 |
regulation of protein serine/threonine kinase activity
|
ADORA1, FLT3, GRM1, HMGCR, IGF1R, MAP2K1, MAP3K7, PDE5A, PTPN1, SRC |
2.9099 |
[BP] GO:0032872 |
regulation of stress-activated MAPK cascade
|
APP, HMGCR, IGF1R, MAP2K1, MAP3K7, PTPN1, XDH |
2.90096 |
[BP] GO:0001816 |
cytokine production
|
APP, FABP4, IDO1, PTAFR, PTGS2 |
2.8974 |
[BP] GO:0070302 |
regulation of stress-activated protein kinase signaling cascade
|
APP, HMGCR, IGF1R, MAP2K1, MAP3K7, PTPN1, XDH |
2.89434 |
[BP] GO:0042391 |
None
|
ADORA1, APP, CACNA1C, GRIA2, GRIA4, GRIK5, GRM5, KDR, SRC |
2.88882 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
2.88882 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, AXL, CYP1A1, CYP1B1, HMGCR, KDR, MAOB, RELA, SRC |
2.87572 |
[BP] GO:0051246 |
regulation of protein metabolic process
|
ADORA1, APP, AR, CDC25B, CSNK2A1, DHFR, F3, FABP4, FLT3, GRM1, GRM5, GSK3B, HMGCR, IGF1R, KDR, MAP2K1, MAP3K7, MMP9, PDE5A, PTAFR, PTGS2, PTPN1, RELA, SRC, XDH |
2.86921 |
[BP] GO:0045860 |
positive regulation of protein kinase activity
|
ADORA1, CDC25B, FLT3, GRM1, GRM5, MAP2K1, MAP3K7, PDE5A, PTPN1, SRC |
2.85179 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
ADORA1, APP, AR, AURKB, CSNK2A1, DHFR, FABP4, GRM3, GRM8, GSK3B, HCAR2, HMGCR, IGF1R, KDR, MAP2K1, MET, MMP12, MMP9, PPARA, PTGS2, PTPN1, RELA, RORC, SRC, XDH |
2.85179 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, APP, CYP19A1, CYP1B1, F3, IGF1R, KDR, MET, MMP9, PTAFR, PTGS2, SRC |
2.83737 |
[BP] GO:0042133 |
neurotransmitter metabolic process
|
ACHE, CYP1B1, DHFR, MAOA, MAOB |
2.79437 |
[BP] GO:0071704 |
organic substance metabolic process
|
ABCG2, ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, APP, AR, AURKB, AXL, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, F3, FABP3, FABP4, FLT3, FUT7, GSK3B, HMGCR, HSD17B1, HSD17B2, HSD17B3, IDO1, IGF1R, KDR, MAOA, MAOB, MAP2K1, MAP3K7, MET, MMP1, MMP12, MMP2, MMP9, PDE5A, PIM1, PPARA, PTAFR, PTGES, PTGS2, PTPN1, RELA, RORC, SRC, TYR, XDH |
2.77958 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADORA1, AKR1B1, APP, AR, AURKB, AXL, CSNK2A1, CYP1B1, F3, FLT3, GRM1, GSK3B, HMGCR, IGF1R, KDR, MAP2K1, MAP3K7, MET, MMP12, MMP9, PDE5A, PTGS2, PTPN1, RELA, SRC, XDH |
2.77319 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AKR1B10, CYP1A1, CYP1A2, CYP1B1, DHFR, IDO1, MAOA, MAOB |
2.76384 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, FABP3, PPARA, SLC1A1 |
2.76384 |
[BP] GO:0080135 |
regulation of cellular response to stress
|
APP, DHFR, GSK3B, HMGCR, IGF1R, MAP2K1, MAP3K7, MET, PTGS2, PTPN1, XDH |
2.75012 |
[BP] GO:0022414 |
reproductive process
|
AKR1B1, APP, AR, AXL, CDC25B, CYP19A1, CYP1A1, HSD17B2, HSD17B3, IDO1, MAP2K1, MMP2, MMP9, PTAFR, PTGS2, SRC |
2.74527 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, PTGES, PTGS2 |
2.72442 |
[BP] GO:0031347 |
regulation of defense response
|
ADORA1, CYP19A1, FABP4, IDO1, MAP3K7, MMP12, MMP2, PPARA, PTGS2, PTPN1, RELA, SRC |
2.69998 |
[BP] GO:0010942 |
positive regulation of cell death
|
CYP1B1, F3, GRIK5, GSK3B, HCAR2, HMGCR, IDO1, MMP9, PTGS2, SRC, XDH |
2.69039 |
[BP] GO:0033674 |
positive regulation of kinase activity
|
ADORA1, CDC25B, FLT3, GRM1, GRM5, MAP2K1, MAP3K7, PDE5A, PTPN1, SRC |
2.64859 |
[BP] GO:0022900 |
electron transport chain
|
AKR1B1, CYP19A1, CYP1A2, IDO1, MAOB, XDH |
2.63329 |
[BP] GO:1901575 |
None
|
ACHE, ADORA1, AKR1B10, AURKB, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, FUT7, GSK3B, IDO1, MAOA, MAOB, PDE5A, XDH |
2.63136 |
[BP] GO:0048878 |
chemical homeostasis
|
ABCG2, AKR1B1, APP, CA12, CA2, CA7, CACNA1C, FABP3, FABP4, GRIK5, GRM1, GRM5, MET |
2.61189 |
[BP] GO:0030335 |
positive regulation of cell migration
|
APP, F3, IGF1R, KDR, MET, MMP9, PTAFR, PTGS2, SRC |
2.6057 |
[BP] GO:0090087 |
None
|
ACHE, ADORA1, APP, CA2, CACNA1C, GSK3B, HCAR2, HMGCR, MMP12, PTGS2, PTPN1, SRC |
2.58741 |
[BP] GO:1903530 |
regulation of secretion by cell
|
ACHE, ADORA1, CACNA1C, CYP19A1, GRIK5, HCAR2, HMGCR, MAOB, MMP12, PTAFR, SRC |
2.58639 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, PTGES, PTGS2 |
2.5745 |
[BP] GO:0051347 |
positive regulation of transferase activity
|
ADORA1, AURKB, CDC25B, FLT3, GRM1, GRM5, MAP2K1, MAP3K7, PDE5A, PTPN1, SRC |
2.57444 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, APP, AXL, CYP1B1, MMP9, PTGS2, RELA, SRC |
2.5698 |
[BP] GO:0051094 |
positive regulation of developmental process
|
APP, AR, AXL, CA2, CYP1B1, F3, HMGCR, IDO1, KDR, MAP2K1, PDE5A, PIM1, PTGS2, RELA, SRC |
2.53716 |
[BP] GO:0006082 |
organic acid metabolic process
|
ABCG2, ALOX5, CYP1A1, CYP1A2, CYP1B1, DHFR, FABP3, IDO1, PIM1, PPARA, PTGES, PTGS2, TYR |
2.52909 |
[BP] GO:0071902 |
positive regulation of protein serine/threonine kinase activity
|
ADORA1, FLT3, GRM1, MAP2K1, MAP3K7, PDE5A, PTPN1, SRC |
2.50585 |
[BP] GO:2000147 |
positive regulation of cell motility
|
APP, F3, IGF1R, KDR, MET, MMP9, PTAFR, PTGS2, SRC |
2.505 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, AXL, CYP1B1, MMP9, RELA, SRC |
2.48801 |
[BP] GO:0099566 |
None
|
GRM1, GRM5 |
2.48258 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.48258 |
[BP] GO:0019222 |
regulation of metabolic process
|
ACHE, ADORA1, ADORA3, APP, AR, AURKB, CDC25B, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, F3, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, GSK3B, HCAR2, HMGCR, IGF1R, KDR, MAOB, MAP2K1, MAP3K7, MET, MMP12, MMP9, PDE5A, PIM1, PPARA, PTAFR, PTGS2, PTPN1, RELA, RORC, SRC, XDH |
2.48097 |
[BP] GO:0009607 |
response to biotic stimulus
|
AXL, CYP1A1, CYP1A2, GSK3B, IDO1, MAOB, MMP12, PTAFR, PTGES, PTGS2, RELA, SRC |
2.45755 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, AXL, CYP1B1, RELA, SRC |
2.4468 |
[BP] GO:0080090 |
regulation of primary metabolic process
|
ADORA1, ADORA3, APP, AR, AURKB, CDC25B, CSNK2A1, CYP1A1, CYP1B1, DHFR, F3, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, GSK3B, HCAR2, HMGCR, IGF1R, KDR, MAOB, MAP2K1, MAP3K7, MET, MMP12, MMP9, PDE5A, PIM1, PPARA, PTAFR, PTGS2, PTPN1, RELA, RORC, SRC, XDH |
2.4468 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
APP, F3, IGF1R, KDR, MET, MMP9, PTAFR, PTGS2, SRC |
2.43302 |
[BP] GO:0097164 |
None
|
ACHE, AKR1B1, AKR1B10, CSNK2A1, MAOA, MAOB |
2.40626 |
[BP] GO:2000243 |
None
|
AR, PDE5A, PTAFR, SRC |
2.40592 |
[BP] GO:0035588 |
None
|
ADORA1, ADORA3, PTAFR |
2.40592 |
[BP] GO:0019752 |
carboxylic acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, DHFR, FABP3, IDO1, PIM1, PPARA, PTGES, PTGS2, TYR |
2.40215 |
[BP] GO:0016310 |
phosphorylation
|
APP, AURKB, AXL, CDC25B, CSNK2A1, FLT3, GSK3B, IGF1R, KDR, MAP2K1, MAP3K7, MET, PIM1, SRC |
2.39894 |
[BP] GO:0048608 |
reproductive structure development
|
AR, AXL, CYP19A1, HSD17B2, HSD17B3, MAP2K1, SRC |
2.39456 |
[BP] GO:0016042 |
lipid catabolic process
|
ADORA1, AKR1B10, CYP19A1, CYP1A2, CYP1B1, FABP3, FABP4 |
2.39456 |
[BP] GO:0032787 |
None
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, FABP3, IDO1, PPARA, PTGES, PTGS2 |
2.39456 |
[BP] GO:0051046 |
None
|
ACHE, ADORA1, CACNA1C, CYP19A1, GRIK5, HCAR2, HMGCR, MAOB, MMP12, PTAFR, SRC |
2.35679 |
[BP] GO:0071498 |
cellular response to fluid shear stress
|
CA2, PTGS2, SRC |
2.35623 |
[BP] GO:0042135 |
None
|
ACHE, MAOA, MAOB |
2.35623 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
2.35623 |
[BP] GO:0006066 |
None
|
AKR1B1, AKR1B10, APP, CYP1B1, DHFR, HMGCR, PTAFR |
2.34495 |
[BP] GO:0043269 |
regulation of ion transport
|
ADORA1, APP, CA2, CA7, CACNA1C, GRM5, MAOB, MMP9, PTAFR, PTGS2 |
2.34495 |
[BP] GO:0040017 |
positive regulation of locomotion
|
APP, F3, IGF1R, KDR, MET, MMP9, PTAFR, PTGS2, SRC |
2.34495 |
[BP] GO:0006950 |
response to stress
|
ACHE, ADORA1, ADORA3, AKR1B1, APP, AXL, CA2, CYP1A1, CYP1A2, CYP1B1, DHFR, GSK3B, IDO1, MAP2K1, MAP3K7, MMP2, MMP9, PPARA, PTAFR, PTGES, PTGS2, PTPN1, RELA, SRC |
2.31304 |
[BP] GO:0070301 |
cellular response to hydrogen peroxide
|
AKR1B1, AXL, CYP1B1, RELA |
2.28482 |
[BP] GO:0034599 |
cellular response to oxidative stress
|
AKR1B1, AXL, CYP1B1, MMP9, RELA, SRC |
2.28258 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, FLT3, IGF1R, KDR, MET, MMP2, MMP9, PTPN1, SRC |
2.27835 |
[BP] GO:0097237 |
cellular response to toxic substance
|
AKR1B1, AXL, CYP1B1, KDR, RELA |
2.27281 |
[BP] GO:1903522 |
None
|
ADORA1, ADORA3, CACNA1C, PDE5A, PTAFR, PTGS2, SLC1A1 |
2.27281 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
ADORA1, APP, CA2, CA7, PTGS2 |
2.26003 |
[BP] GO:0010675 |
None
|
GSK3B, PPARA, PTAFR, RORC, SRC |
2.26003 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.25724 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
CA2, CA7 |
2.25322 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.25322 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
FABP3, FLT3, PPARA, PTGS2, SRC |
2.23668 |
[BP] GO:0001819 |
positive regulation of cytokine production
|
CYP1B1, IDO1, MAP3K7, MMP12, PTAFR, PTGS2, RELA, SRC |
2.22793 |
[BP] GO:0044248 |
cellular catabolic process
|
ACHE, AKR1B10, AURKB, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, GSK3B, IDO1, MAOA, MAOB, PDE5A, SRC, XDH |
2.22153 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, HMGCR |
2.20934 |
[BP] GO:0010634 |
positive regulation of epithelial cell migration
|
KDR, MET, MMP9, PTGS2, SRC |
2.20934 |
[BP] GO:0030574 |
collagen catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.20493 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
HMGCR, IGF1R, MET, MMP9, PTGS2, PTPN1, RELA, SRC, XDH |
2.18766 |
[BP] GO:0044057 |
None
|
ADORA1, ADORA3, CACNA1C, GRM1, HCAR2, PDE5A, PTAFR, PTGS2, SLC1A1 |
2.17635 |
[BP] GO:0043281 |
regulation of cysteine-type endopeptidase activity involved in apoptotic process
|
CSNK2A1, F3, MMP9, PTGS2, SRC, XDH |
2.17004 |
[BP] GO:0045932 |
None
|
ADORA1, PDE5A, PTGS2 |
2.16793 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
ADORA1, CA2, CA7, CACNA1C, KDR, SRC |
2.15127 |
[BP] GO:0046683 |
response to organophosphorus
|
APP, PTAFR, PTGS2, RELA, TYR |
2.14312 |
[BP] GO:0008283 |
cell proliferation
|
ACHE, AR, AURKB, CYP1A1, FLT3, MAP2K1, MET, PIM1, SRC, TYR |
2.13097 |
[BP] GO:2001234 |
negative regulation of apoptotic signaling pathway
|
AR, MMP9, PTGS2, PTPN1, RELA, SRC |
2.1256 |
[BP] GO:0060079 |
None
|
ADORA1, GRIA2, GRIA4, GRIK5 |
2.12193 |
[BP] GO:0030198 |
extracellular matrix organization
|
APP, CYP1B1, KDR, MMP1, MMP12, MMP2, MMP9 |
2.10736 |
[BP] GO:0043062 |
extracellular structure organization
|
APP, CYP1B1, KDR, MMP1, MMP12, MMP2, MMP9 |
2.1 |
[BP] GO:0050789 |
regulation of biological process
|
ACHE, ADORA1, ADORA3, AKR1B1, APP, AR, AURKB, AXL, CA1, CA2, CA7, CACNA1C, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, F3, FABP3, FABP4, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, GSK3B, HCAR2, HMGCR, IDO1, IGF1R, KDR, MAOB, MAP2K1, MAP3K7, MET, MMP1, MMP12, MMP2, MMP9, PDE5A, PIM1, PPARA, PTAFR, PTGES, PTGS2, PTPN1, RELA, RORC, SLC1A1, SRC, XDH |
2.09172 |
[BP] GO:0031349 |
positive regulation of defense response
|
FABP4, IDO1, MAP3K7, MMP12, MMP2, PTGS2, RELA, SRC |
2.09172 |
[BP] GO:0043436 |
oxoacid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, DHFR, FABP3, IDO1, PIM1, PPARA, PTGES, PTGS2, TYR |
2.07606 |
[BP] GO:0061370 |
testosterone biosynthetic process
|
CYP19A1, HSD17B3 |
2.07606 |
[BP] GO:0010641 |
None
|
F3, SRC |
2.07606 |
[BP] GO:0051171 |
regulation of nitrogen compound metabolic process
|
ADORA1, ADORA3, APP, AR, AURKB, CDC25B, CSNK2A1, CYP1B1, DHFR, F3, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, GSK3B, HMGCR, IGF1R, KDR, MAOB, MAP2K1, MAP3K7, MET, MMP12, MMP9, PDE5A, PIM1, PPARA, PTAFR, PTGS2, PTPN1, RELA, RORC, SRC, XDH |
2.06136 |
[BP] GO:0043207 |
response to external biotic stimulus
|
AXL, CYP1A1, CYP1A2, IDO1, MAOB, MMP12, PTAFR, PTGES, PTGS2, RELA, SRC |
2.06136 |
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, FABP3, PPARA, SLC1A1 |
2.05168 |
[BP] GO:0035587 |
None
|
ADORA1, ADORA3, PTAFR |
2.05117 |
[BP] GO:0007167 |
enzyme linked receptor protein signaling pathway
|
AXL, FLT3, IGF1R, KDR, MAP3K7, MET, MMP2, MMP9, PTPN1, SRC |
2.05117 |
[BP] GO:0044243 |
multicellular organismal catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.05101 |
[BP] GO:0050794 |
regulation of cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, APP, AR, AURKB, AXL, CA1, CA2, CA7, CACNA1C, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DHFR, F3, FABP3, FABP4, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, GSK3B, HCAR2, HMGCR, IDO1, IGF1R, KDR, MAOB, MAP2K1, MAP3K7, MET, MMP1, MMP12, MMP2, MMP9, PDE5A, PIM1, PPARA, PTAFR, PTGES, PTGS2, PTPN1, RELA, RORC, SRC, XDH |
2.05101 |
[BP] GO:0061097 |
None
|
ADORA1, APP, GRM5, PTPN1 |
2.03187 |
[BP] GO:0031323 |
regulation of cellular metabolic process
|
ACHE, ADORA1, ADORA3, APP, AR, AURKB, CDC25B, CSNK2A1, CYP1B1, DHFR, F3, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, GSK3B, HMGCR, IGF1R, KDR, MAOB, MAP2K1, MAP3K7, MET, MMP12, MMP9, PDE5A, PIM1, PPARA, PTAFR, PTGS2, PTPN1, RELA, RORC, SRC, XDH |
2.03048 |
[BP] GO:0051050 |
positive regulation of transport
|
ACHE, ADORA1, APP, AXL, CA2, CYP19A1, GSK3B, HCAR2, MMP12, PTAFR, PTGS2, SRC |
2.02829 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADORA1, AR, GSK3B, HMGCR, IGF1R, MET, MMP12, MMP9, PTGS2, PTPN1, RELA, SRC, XDH |
2.00459 |
[CC] GO:0016020 |
membrane
|
ABCG2, ACHE, ADORA1, ADORA3, ALOX5, APP, AR, AXL, CA12, CA14, CA2, CA4, CACNA1C, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, F3, FLT3, FUT7, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, GSK3B, HCAR2, HMGCR, HSD17B2, HSD17B3, IGF1R, KDR, MAOA, MAOB, MAP2K1, MAP3K7, MET, MMP2, PIM1, PTAFR, PTGES, PTGS2, PTPN1, SLC1A1, SRC, TYR |
4.08834 |
[CC] GO:0005886 |
plasma membrane
|
ABCG2, ACHE, ADORA1, ADORA3, APP, AR, AXL, CA12, CA14, CA2, CA4, CACNA1C, CSNK2A1, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, GSK3B, HCAR2, IGF1R, KDR, MAP2K1, MAP3K7, MET, MMP2, PIM1, PTAFR, PTPN1, SLC1A1, SRC |
4.07644 |
[CC] GO:0044456 |
None
|
ACHE, ADORA1, APP, CACNA1C, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, GSK3B, SRC |
3.77719 |
[CC] GO:0098590 |
plasma membrane region
|
ABCG2, ADORA1, CA2, CA4, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, MET, PTGS2, SLC1A1, SRC |
3.62687 |
[CC] GO:0005641 |
nuclear envelope lumen
|
ALOX5, APP, PTGES |
3.45865 |
[CC] GO:0042734 |
None
|
GRIK5, GRM1, GRM3, GRM5, GRM8 |
3.41483 |
[CC] GO:0014069 |
None
|
ADORA1, CACNA1C, GRIK5, GRM1, GRM3, GRM5, SRC |
3.09812 |
[CC] GO:0099572 |
None
|
ADORA1, CACNA1C, GRIK5, GRM1, GRM3, GRM5, SRC |
3.09812 |
[CC] GO:0044459 |
plasma membrane part
|
ABCG2, ADORA1, ADORA3, APP, AXL, CA2, CA4, CACNA1C, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, PTAFR, PTGS2, SLC1A1, SRC |
2.98172 |
[CC] GO:0031226 |
intrinsic component of plasma membrane
|
ADORA1, ADORA3, APP, AXL, CA4, F3, FLT3, GRIA2, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, PTAFR, SLC1A1 |
2.8974 |
[CC] GO:0098794 |
None
|
ADORA1, APP, GRIA2, GRIA4, GRM3, GSK3B |
2.76384 |
[CC] GO:0005783 |
None
|
ADORA1, APP, CA4, CYP19A1, FLT3, GRIK5, HMGCR, HSD17B3, KDR, MAP2K1, PTGS2, PTPN1, XDH |
2.62443 |
[CC] GO:0044444 |
cytoplasmic part
|
ABCG2, ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, APP, AR, AURKB, CA1, CA2, CA4, CA7, CACNA1C, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, FABP3, FABP4, FLT3, FUT7, GRIA2, GRIA4, GRIK5, GSK3B, HMGCR, HSD17B1, HSD17B2, HSD17B3, IDO1, KDR, MAOA, MAOB, MAP2K1, MAP3K7, MMP2, MMP9, PDE5A, PIM1, PTAFR, PTGES, PTGS2, PTPN1, RELA, SRC, TYR, XDH |
2.5745 |
[CC] GO:0044425 |
membrane part
|
ABCG2, ACHE, ADORA1, ADORA3, APP, AXL, CA12, CA14, CA2, CA4, CACNA1C, CYP19A1, CYP1A1, CYP1A2, CYP1B1, F3, FLT3, FUT7, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HMGCR, HSD17B2, HSD17B3, IGF1R, KDR, MAOA, MAOB, MET, PTAFR, PTGES, PTGS2, PTPN1, SLC1A1, SRC, TYR |
2.52736 |
[CC] GO:0043197 |
None
|
ADORA1, APP, GRIA2, GRIA4, GRM3 |
2.29961 |
[CC] GO:0044309 |
None
|
ADORA1, APP, GRIA2, GRIA4, GRM3 |
2.27281 |
[CC] GO:0097060 |
None
|
GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
2.25831 |
[CC] GO:0005887 |
integral component of plasma membrane
|
ADORA1, ADORA3, APP, AXL, FLT3, GRIA2, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, PTAFR, SLC1A1 |
2.12092 |
[CC] GO:0043005 |
None
|
ADORA1, APP, CA2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, PTGS2, SRC |
2.11799 |
[CC] GO:0043235 |
receptor complex
|
ABCG2, APP, GRIA2, GRIA4, GRIK5, GRM1, IGF1R |
2.01595 |
[MF] GO:0043167 |
ion binding
|
ABCG2, ACHE, ALOX5, APP, AR, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CACNA1C, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, F3, FABP3, FABP4, FLT3, GSK3B, HMGCR, HSD17B1, IDO1, IGF1R, KDR, MAOB, MAP2K1, MAP3K7, MET, MMP1, MMP12, MMP2, MMP9, PDE5A, PIM1, PPARA, PTAFR, PTGES, PTGS2, PTPN1, RELA, RORC, SLC1A1, SRC, TYR, XDH |
8.54744 |
[MF] GO:0008066 |
None
|
GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
8.04498 |
[MF] GO:0003824 |
catalytic activity
|
ABCG2, ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, F3, FLT3, FUT7, GSK3B, HMGCR, HSD17B1, HSD17B2, HSD17B3, IDO1, IGF1R, KDR, MAOA, MAOB, MAP2K1, MAP3K7, MET, MMP1, MMP12, MMP2, MMP9, PDE5A, PIM1, PTGES, PTGS2, PTPN1, SRC, TYR, XDH |
7.95367 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA7 |
7.86662 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX5, APP, AR, CA1, CA12, CA2, CA4, CA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, TYR, XDH |
7.85075 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, HMGCR, HSD17B1, HSD17B2, HSD17B3, IDO1, MAOA, MAOB, PTGS2, TYR, XDH |
7.21525 |
[MF] GO:0048037 |
cofactor binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, HMGCR, HSD17B1, IDO1, MAOB, PTGES, PTGS2, SRC, XDH |
5.24048 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, AR, AXL, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, KDR, MET, PPARA, PTAFR, RORC |
4.87793 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7 |
4.85801 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA1, ADORA3, AR, AXL, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, KDR, MAP2K1, MAP3K7, MET, PPARA, PTAFR, RORC |
4.71651 |
[MF] GO:0043168 |
anion binding
|
ABCG2, APP, AURKB, AXL, CSNK2A1, DHFR, F3, FABP3, FABP4, FLT3, GSK3B, HMGCR, HSD17B1, IGF1R, KDR, MAOB, MAP2K1, MAP3K7, MET, PDE5A, PIM1, PTAFR, PTGES, RELA, SLC1A1, SRC, XDH |
4.20637 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7 |
4.18953 |
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA3, AR, AXL, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, KDR, MET, PPARA, PTAFR, RORC |
4.17474 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, IDO1, PTGS2, SRC |
4.09111 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA3, AR, AXL, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, KDR, MET, PPARA, PTAFR, RORC |
4.01048 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, HMGCR, HSD17B1, HSD17B2, HSD17B3, XDH |
3.96634 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, IDO1, PTGS2, SRC |
3.93498 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
3.67085 |
[MF] GO:0099600 |
transmembrane receptor activity
|
ADORA1, ADORA3, AXL, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, KDR, MET, PTAFR |
3.64635 |
[MF] GO:0004888 |
transmembrane signaling receptor activity
|
ADORA1, ADORA3, AXL, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, KDR, MET, PTAFR |
3.64635 |
[MF] GO:0008144 |
drug binding
|
ABCG2, ACHE, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, FLT3, GSK3B, IGF1R, KDR, MAP2K1, MAP3K7, MET, PIM1, PPARA, SRC |
3.61752 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
3.50405 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, CYP19A1, CYP1A2, IDO1, MAOB, XDH |
3.45865 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.41483 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CSNK2A1, FLT3, GSK3B, IGF1R, KDR, MAP2K1, MAP3K7, MET, PIM1, SRC |
3.37876 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MAP2K1, MET, SRC |
3.30735 |
[MF] GO:0016616 |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1B1, AKR1B10, HMGCR, HSD17B1, HSD17B2, HSD17B3 |
3.26342 |
[MF] GO:0008270 |
zinc ion binding
|
AR, CA1, CA12, CA2, CA4, CA7, MMP1, MMP12, MMP2, MMP9, PPARA, PTPN1, RORC |
3.19844 |
[MF] GO:0036094 |
small molecule binding
|
ABCG2, ADORA1, AURKB, AXL, CSNK2A1, DHFR, FABP3, FABP4, FLT3, GSK3B, HMGCR, HSD17B1, IGF1R, KDR, MAOB, MAP2K1, MAP3K7, MET, PDE5A, PIM1, SLC1A1, SRC, XDH |
3.10055 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
2.98172 |
[MF] GO:0042562 |
hormone binding
|
ACHE, AR, HSD17B1, IGF1R, SHBG |
2.85963 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, PTGS2, TYR |
2.72442 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
AURKB, AXL, CSNK2A1, FLT3, GSK3B, IGF1R, KDR, MAP2K1, MAP3K7, MET, PIM1, SRC |
2.71244 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
2.71167 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, TYR |
2.66056 |
[MF] GO:0005506 |
iron ion binding
|
ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, XDH |
2.65804 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX5, APP, AR, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CACNA1C, CYP19A1, CYP1A1, CYP1A2, CYP1B1, IDO1, MAP3K7, MMP1, MMP12, MMP2, MMP9, PDE5A, PIM1, PPARA, PTGS2, PTPN1, RORC, SLC1A1, TYR, XDH |
2.64262 |
[MF] GO:0099583 |
None
|
GRM1, GRM5 |
2.48258 |
[MF] GO:0004970 |
None
|
GRIA2, GRIA4, GRIK5 |
2.45691 |
[MF] GO:0005234 |
None
|
GRIA2, GRIA4, GRIK5 |
2.45691 |
[MF] GO:0046872 |
metal ion binding
|
ALOX5, APP, AR, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CACNA1C, CYP19A1, CYP1A1, CYP1A2, CYP1B1, IDO1, MAP3K7, MMP1, MMP12, MMP2, MMP9, PDE5A, PIM1, PPARA, PTGS2, PTPN1, RORC, SLC1A1, TYR, XDH |
2.45072 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, ADORA1, CSNK2A1, FLT3, IGF1R, KDR, MMP12, MMP9, PIM1, PPARA, PTPN1, RELA, SRC |
2.45072 |
[MF] GO:0030594 |
None
|
GRIA2, GRIA4, GRIK5, GRM1, GRM5 |
2.4323 |
[MF] GO:0042802 |
identical protein binding
|
ABCG2, ACHE, APP, CSNK2A1, FLT3, GRIK5, HMGCR, IGF1R, KDR, MAOB, MAP3K7, MET, MMP9, PTGS2, RELA, TYR, XDH |
2.4323 |
[MF] GO:0016301 |
kinase activity
|
AURKB, AXL, CSNK2A1, FLT3, GSK3B, IGF1R, KDR, MAP2K1, MAP3K7, MET, PIM1, SRC |
2.40626 |
[MF] GO:0016829 |
lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7 |
2.39287 |
[MF] GO:0004971 |
None
|
GRIA2, GRIA4 |
2.25322 |
[MF] GO:0005497 |
None
|
AR, SHBG |
2.25322 |
[MF] GO:0035586 |
None
|
ADORA1, ADORA3, PTAFR |
2.16793 |
[MF] GO:0000166 |
nucleotide binding
|
ABCG2, AURKB, AXL, CSNK2A1, DHFR, FLT3, GSK3B, HMGCR, HSD17B1, IGF1R, KDR, MAOB, MAP2K1, MAP3K7, MET, PDE5A, PIM1, SRC, XDH |
2.14831 |
[MF] GO:1901265 |
nucleoside phosphate binding
|
ABCG2, AURKB, AXL, CSNK2A1, DHFR, FLT3, GSK3B, HMGCR, HSD17B1, IGF1R, KDR, MAOB, MAP2K1, MAP3K7, MET, PDE5A, PIM1, SRC, XDH |
2.14695 |
[MF] GO:0016702 |
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen
|
ALOX5, IDO1, PTGS2 |
2.1256 |
[MF] GO:0032403 |
protein complex binding
|
ACHE, ADORA1, FLT3, IGF1R, KDR, MMP12, MMP9, PPARA, PTPN1, RELA, SRC |
2.11799 |
[MF] GO:0033764 |
steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
HSD17B1, HSD17B2, HSD17B3 |
2.08938 |
[MF] GO:0016701 |
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen
|
ALOX5, IDO1, PTGS2 |
2.08938 |
[MF] GO:0008289 |
lipid binding
|
AR, AXL, F3, FABP3, FABP4, HSD17B1, PPARA, PTAFR, RORC, SHBG |
2.04462 |
[MF] GO:0016229 |
steroid dehydrogenase activity
|
HSD17B1, HSD17B2, HSD17B3 |
2.01595 |